Alexandria Real Estate Equities, Inc. reports news as a life science real estate investment trust that owns, operates and develops collaborative Megacampus™ ecosystems in major life science innovation clusters. Company updates commonly cover operating results, funds from operations, leasing activity, rental-rate trends and property-market demand across locations such as Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle and New York City.
Recurring announcements also include quarterly common stock dividends, balance-sheet and liquidity commentary, capital recycling activity, senior note offerings, cash tender offers for outstanding debt and corporate governance or leadership matters tied to the REIT’s public-company structure.
Summary not available.
Alexandria Real Estate Equities (NYSE:ARE) reported strong financial results for Q1 2022, with total revenues increasing by 28.2% to $615.1 million compared to Q1 2021. Net loss attributable to common stockholders was $151.7 million, resulting in a diluted loss of $0.96 per share. The company maintained robust leasing activity, achieving a second-highest leasing volume in its history. Notably, a sale of a 70% interest in 100 Binney Street generated $713.2 million, providing cash for future opportunities. Alexandria continues to focus on growth with significant capital investments and strategic acquisitions.
Summary not available.
Alexandria Real Estate Equities (NYSE: ARE) announced the election of Cynthia L. Feldmann as an independent director on March 25, 2022. Feldmann brings extensive experience in life sciences and finance, having previously held leadership roles at KPMG and Coopers & Lybrand. She has served on several boards, enhancing her credibility. Her term will last until the 2022 annual stockholders' meeting. The board believes her expertise will significantly benefit Alexandria's strategic direction and future growth.
Alexandria Real Estate Equities (NYSE: ARE) announces the participation of its executive chairman, Joel S. Marcus, in the groundbreaking ceremony for the National Medal of Honor Museum in Arlington, Texas, on March 25, 2022. The museum aims to honor Medal of Honor recipients and will include an education center for youth. Funded by private donations, the museum has raised $165 million of its $215 million goal and is set to open in 2024. Alexandria expresses pride in supporting this historic project, emphasizing the importance of honoring American valor and inspiring future generations.
Alexandria Real Estate Equities (NYSE: ARE) has achieved the first Fitwel Life Science certification for its 300 Technology Square facility in Cambridge, marking a significant milestone in healthy building practices for laboratory facilities. Developed in partnership with the Center for Active Design, this scorecard focuses on tenant health, emphasizing design features like indoor air quality, enhanced cleaning, and access to green space. Alexandria aims to enhance health and wellness across its facilities, underpinning its commitment to leading practices in the market.
Alexandria Real Estate Equities (NYSE: ARE) has secured a significant long-term lease with Bristol Myers Squibb for a new 427,000 RSF R&D facility at Alexandria Point in San Diego. This lease is the second-largest in Alexandria's history and underscores their strategic relationship with BMS, which has spanned over two decades. The new mega campus will total over 2 million square feet and includes various amenities to foster collaboration and innovation. Alexandria is also targeting LEED Gold certification, enhancing sustainability features in the development.
Alexandria Real Estate Equities (NYSE: ARE) announced a quarterly cash dividend of $1.15 per common share for Q1 2022, payable on April 15, 2022, to shareholders of record by March 31, 2022. This reflects a 6% increase over the previous year's total of $4.54 per common share. The company's funds from operations (FFO) payout ratio remains low at 60%, allowing for continued expansion and reinvestment in high-quality properties while rewarding shareholders. Alexandria focuses on life science and technology campuses in key innovation clusters.
Alexandria Real Estate Equities (NYSE: ARE) announced a conference call on April 26, 2022, at 3:00 p.m. ET, to discuss its first quarter 2022 operating and financial results. The results will be released after market close on April 25, 2022. The call can be accessed by dialing (833) 366-1125 or (412) 902-6738, and a live audio webcast will be available on the company's website. A replay of the call will be accessible from 5:00 p.m. ET on April 26 to 5:00 p.m. ET on May 3, 2022.
Alexandria Real Estate Equities (NYSE: ARE) has announced a significant milestone with Eli Lilly signing a 334,000 RSF long-term lease for its new Institute for Genetic Medicine at 15 Necco Street, Greater Boston. This development, set to open in late 2023, underscores Alexandria's status as a leading urban office REIT focused on life sciences. With a market cap of $44 billion and over 18 million square feet in Greater Boston, Alexandria continues to meet the increasing demand in the life sciences sector while enhancing local infrastructure.